Sánchez-Tejerina, D.; Sotoca, J.; Llaurado, A.; López-Diego, V.; Juntas-Morales, R.; Salvado, M.
New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies. J. Clin. Med. 2022, 11, 6394.
https://doi.org/10.3390/jcm11216394
AMA Style
Sánchez-Tejerina D, Sotoca J, Llaurado A, López-Diego V, Juntas-Morales R, Salvado M.
New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies. Journal of Clinical Medicine. 2022; 11(21):6394.
https://doi.org/10.3390/jcm11216394
Chicago/Turabian Style
Sánchez-Tejerina, Daniel, Javier Sotoca, Arnau Llaurado, Veronica López-Diego, Raul Juntas-Morales, and Maria Salvado.
2022. "New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies" Journal of Clinical Medicine 11, no. 21: 6394.
https://doi.org/10.3390/jcm11216394
APA Style
Sánchez-Tejerina, D., Sotoca, J., Llaurado, A., López-Diego, V., Juntas-Morales, R., & Salvado, M.
(2022). New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies. Journal of Clinical Medicine, 11(21), 6394.
https://doi.org/10.3390/jcm11216394